v3.24.1.1.u2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net income $ 6,562 $ 9,735
Adjustments to reconcile net income to net cash (used for) provided by operating activities:    
Provision for credit losses 2,727 1,660
Provision for (reversal of) credit losses on unfunded commitments 142 (19)
Provision for mortgage put-back reserve, net 13 5
Net amortization (accretion) on investments 60 (34)
Premises and equipment depreciation 85 73
Lease asset amortization 238 266
Increase in cash surrender value of BOLI (351) (257)
Executive long-term incentive plan expense 149 152
Stock-based compensation expense 472 438
Director and employee compensation paid in Company stock 515 547
Deferred income tax benefit (7) (65)
Gain on sale of securities available for sale 0 1
Valuation allowance on derivatives 0 9
Increase in valuation of loans held for sale carried at fair value 0 6
Proceeds from sales of loans held for sale 37,555 42,238
Originations of loans held for sale (40,377) (44,448)
Changes in assets and liabilities:    
Accrued interest receivable (764) (496)
Taxes payable 489 2,927
Accounts receivable (10,582) (105)
Other assets 1,697 191
Accrued interest payable 426 946
Other liabilities (2,461) (3,414)
Net cash (used for) provided by operating activities (3,412) 10,356
Cash flows from investing activities    
Purchases of securities available for sale (15,362) 0
Proceeds from calls and maturities of securities available for sale 20,788 490
Net (purchases) sales of restricted investments (88) 3,147
Net increase in portfolio loans receivable (63,224) (60,023)
Net sales (purchases) of premises and equipment 246 (2,320)
Net cash used in investing activities (57,640) (58,706)
Net increase (decrease) in:    
Noninterest-bearing deposits 48,439 31,488
Interest-bearing deposits 61,260 154,814
Federal Home Loan Bank repayments 0 (75,000)
Other borrowed funds (15,000) 0
Dividends paid (1,115) (850)
Repurchase of common stock (1,399) (2,719)
Net proceeds from exercise of stock options 107 589
Net cash provided by financing activities 92,292 108,322
Net increase in cash and cash equivalents 31,240 59,972
Cash and cash equivalents, beginning of year 53,964 80,415
Cash and cash equivalents, end of period 85,204 140,387
Noncash investing and financing activities:    
Change in unrealized (losses) gains on investments (589) 3,736
Cash paid during the period for:    
Taxes 36 35
Interest $ 12,935 $ 5,920